Exhibit 24

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HRZZlYk1TiD+RMpE4o4lGVN/hFR7S8SKvi0DlNkWEstK2vzXWBmwMtkKfUSrSQiW DuU7nyP5wXAXfq4zkVChsA== 0001176256-08-000475.txt : 20080410 0001176256-08-000475.hdr.sgml : 20080410 20080410165201 ACCESSION NUMBER: 0001176256-08-000475 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080410 DATE AS OF CHANGE: 20080410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANGIOTECH PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001096481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Willms Arthur H CENTRAL INDEX KEY: 0001431988 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30334 FILM NUMBER: 08750449 BUSINESS ADDRESS: BUSINESS PHONE: 604-221-7676 MAIL ADDRESS: STREET 1: 1618 STATION STREET CITY: VANCOUVER STATE: A1 ZIP: V6A 1B6 3 1 primary_doc.xml PRIMARY DOCUMENT X0202 3 2008-03-31 0 0001096481 ANGIOTECH PHARMACEUTICALS INC ANPI 0001431988 Willms Arthur H 1618 STATION STREET VANCOUVER A1 V6A 1B6 BRITISH COLUMBIA, CANADA 1 0 0 0 Common Stock 30500 D Awards 27.75 2004-07-01 2009-06-09 Common Stock 10000 D Awards 21.93 2005-01-01 2009-11-30 Common Stock 5000 D Awards 16.1 2005-06-10 2010-06-08 Common Stock 5000 D Awards 17.11 2006-01-01 2010-11-30 Common Stock 5000 D Awards 14.86 2006-01-01 2011-06-07 Common Stock 5000 D Awards 10.01 2007-01-01 2011-11-30 Common Stock 5000 D Awards 7.73 2007-07-01 2012-06-17 Common Stock 5000 D Awards 3.96 2008-01-01 2012-11-30 Common Stock 5000 D The option is currently exercisable as to all 10000 shares. The option became exercisable on 7/1/2004 having vested in 24 equal installments over two years with the last installment vesting on 6/1/2006. The option is currently exercisable as to all 5000 shares. The option became exercisable on 1/1/2005 having vested in 24 equal installments over two years with the last installment vesting on 12/1/2006. The option is currently exercisable as to all 5000 shares. The option became exercisable on 6/10/2005 having vested in 24 equal installments over two years with the last installment vesting on 6/9/2007. The option is currently exercisable as to all 5000 shares. The option became exercisable on 1/1/2006 having vested in 24 equal installments over two years with the last installment vesting on 12/1/2007. The option is currently exercisable as to 33750 shares. The option became exercisable on 1/1/2006 and will continue to vest with respect to the remaining 26250 shares in equal installments on a monthly basis until 12/1/2009. The option is currently exercisable as to 3125 shares. The option became exercisable on 1/1/2007 and will continue to vest with respect to the remaining 1875 shares in equal installments on a monthly basis until 12/1/2008. The option is currently exercisable as to 1875 shares. The option became exercisable on 7/1/2007 and will continue to vest with respect to the remaining 3125 shares in equal installments on a monthly basis until 6/1/2009. The option is currently exercisable as to 625 shares. The option became exercisable on 1/1/2008 and will continue to vest with respect to the remaining (Unvested) shares in equal installments on a monthly basis until 12/1/2009. All Conversion or Exercise Prices are in Canadian Funds. /s/ David M. Hall as attorney-in-fact for Arthur Willms 2008-04-10 EX-24 2 exhibit24willms.htm POWER OF ATTORNEY Exhibit 24

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of David M. Hall and Jay Dent and each of them individually, the undersigned’s true and lawful attorney-in-fact to:

(1)

Execute for and on behalf of the undersigned, in the undersigned’s capacity as an Officer and/or Director of Angiotech Pharmaceuticals, Inc., a corporation organized under the Business Corporations Act (British Columbia) (the “Company”), Forms 3, 4 and 5 and any other forms required to be filed in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder (a “Section 16 Form”) and a Form ID and any other forms required to be filed or submitted in accordance with Regulation S-T promulgated by the United States Securities and Exchange Commission (or any successor provision) in order to file the Section 16 Forms electronically (a “Form ID”, and, together with the Section 16 Forms, a “Form”);

(2)

Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and the NASDAQ; and

(3)

Take any other action of any type whatsoever in connection with the foregoing which, in the opinion of each such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by each such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as he may approve in his discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that each such attorney-in-fact is serving in such capacity at the request of the undersigned, and is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

The Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Forms pursuant to Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each such attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be

executed as of this 9^th day of April, 2008.

__/s/ Arthur Willms___________

Signature

__Arthur Willms_______________

Name

-----END PRIVACY-ENHANCED MESSAGE-----